Dear Visitor, We at RSP Systems, are currently working hard to update our website so that it has the most up to date information about our product, market launch, team, and technology. Please excuse our mess as we experiment with style and form to develop a website that expresses clearly who we are as a company. Please feel free to contact us with any questions you may have about our device or technology. We would be happy to start a dialogue with you.
Two new colleagues have stepped into the RSP office during October and November.
Continue reading “New bright minds join RSP”
The growth of RSP Systems continues with the appointment of QA/RA Engineer.
We are happy to announce that RSP Systems have strengthened its Quality & Regulatory department with a QA Engineer
Continue reading “Appointment of new QA/RA Engineer”
Several new members of staff have joined RSP to support the development of the business.
Continue reading “Several new members of staff have joined RSP”
RSP Systems (“RSP”), the non-invasive human diagnostics company, announces today that it’s been awarded a EUR2.4 million grant.
Continue reading “Awarded EUR2.4 mil. grant by the EU’s Horizon 2020 framework”
RSP initiates an extensive clinical study in collaboration with Odense University Hospital. The Hospital is a leading partner within the diabetes care and research field. This study involves 72 diabetics, and runs until Q4 2016. Purpose of the study is to demonstrate the accuracy of RSP Systems’ 3rd generation prototype of the GlucoBeam®. GlucoBeam® is a non-invasive glucose monitor based on the company’s proprietary and patented optical Raman technology.
Continue reading “New clinical study tests Non-Invasive Glucose measurement accuracy under home measurement conditions”